Rohit Aggarwal, MD, MS

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Janssen
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Kezar
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Kyverna
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Mallinckrodt
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Manta Medicines Corporation
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Novartis
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Nuvig Therapeutics
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Octapharma
    Date added:
    04/04/2024
    Date updated:
    08/20/2024

Pages

Return to 2024 Inova Fairfax Medicine Grand Rounds 08/20/2024